Pharming Group share price logo

Pharming Group

NASDAQ: PHAR

Small Cap

$9.53

-0.12

(-1.24%)

as on

Pharming Group Stock Performance

as on October 9, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $9.44
    $9.65
    downward going graph

    0.94%

    Downside

    1.26%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $9.44
    $21.34
    downward going graph

    0.93%

    Downside

    123.92%

    Upside

    downward going graph

Pharming Group share price movements today

Previous Close
$9.65
Open
$9.65
Volume
98.7K
Market Cap
$683.0M
Day's Low - High
$9.44 - $9.65
52 Week Low - High
$9.44 - $21.34

Pharming Group Historical Returns

1 Month Return
-13.13 %
3 Month Return
-32.12 %
1 Year Return
-34.67 %
3 Year Return
-18.62 %
5 Year Return
+ 1.17 %

Pharming Group Stock Fundamentals & Key Indicators

Check Pharming Group market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$683.0M

EPS (TTM)

0.138

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

65.58

Industry PE ratio

-6.50

PEG Ratio

0.00

EBITDA

42.6M

Revenue (TTM)

366.4M

Profit Margin

86.50%

Return On Equity TTM

3.52%

Pharming Group vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharming Group with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Pharming Group image
Pharming Group
Buy$683.0M1.17%65.5886.50%0.00%
Moderna image
Moderna
Neutral$78.4B-35.39%-24.62-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$128.2B181.24%29.1986.04%0.00%
Regeneron image
Regeneron
Buy$76.1B34.46%17.7284.86%0.50%

Stock Returns calculator for Pharming Group Stock including INR - Dollar returns

The Pharming Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pharming Group investment value today

Current value as on today

₹71,233

Returns

-₹28,767

(-28.77%)

Returns from Pharming Group Stock

-₹34,670 (-34.67%)

Dollar Impact

₹5,903 (+5.9%)

Analyst Recommendation on Pharming Group Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Pharming Group. Average target price of $34.35

Pharming Group Share Price Target

Get share price movements and forecasts by analysts on Pharming Group.

What analysts predicted

72.26%UPSIDE

Target Price

$34.35

Current Price

$9.53

Analyzed by

2 Analysts

High

$38

Target

$34.35

Low

$37

Pharming Group target price $34.35, a slight upside of 72.26% compared to current price of $9.53. According to 2 analysts rating.

Indian Investors' Interest in Pharming Group Stock

Search interest for Pharming Group Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2% versus previous 30 day period

Pharming Group Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
55
74
74
92,700
79
93
97
106
72
90
Gross Profit
47
66
68
80,500
70
84
90
85
65
75
Operating Income
-16
-3
3
6,600
-7
9
15
2
-5
0
EBITDA
-9
1
7
6,707
-4
9
23
9
1
8
Interest Expense
1
1
2
1
5
0
7
1
2
2
Depreciation
5
-
2
7
2
2
2
3
3
3
Income Before Tax
-16
0
1
6,700
-11
7
12
4
-4
3
Income Tax Expense
-4
1
2
3,800
3
2
5
0
0
1
Net Income
-12
-1
-1
2,900
-14
4
7
5
-5
1
Net Profit Margin
84.91%
89.20%
90.89%
86.82%
89.48%
90.38%
92.73%
80.19%
90.83%
83.88%

Pharming Group Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
107
154
189
212
198
205
245
297
376
Gross Profit
92
129
165
188
177
188
220
261
330
Operating Income
26
43
68
76
19
9
-22
-3
20
EBITDA
-76
24
71
58
48
33
9
16
34
Interest Expense
45
16
13
10
7
5
5
9
10
Depreciation
4
7
5
8
19
13
15
16
11
Income Before Tax
-102
0
52
44
23
14
-12
-8
12
Income Tax Expense
-11
-27
11
6
7
1
-1
3
10
Net Income
-91
28
40
37
15
13
-10
-11
2
Net Profit Margin
86.11%
83.59%
87.37%
88.91%
89.37%
91.46%
89.72%
88.09%
87.90%

Pharming Group Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
0
1
6
-11
7
12
4
-4
3
Operating Cash Flow
-7
-13
9
9
0
11
32
10
1
-12
Investing Cash Flow
0
36
4
-9
9
16
0
0
-84
0
Financing Cash Flow
-2
-28
-1
-2
-6
-2
9
1
-9
0
Change in Cash
-9
-4
13
-5
5
31
40
12
-92
105

Pharming Group Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
26
0
52
44
23
14
-12
-8
12
Operating Cash Flow
45
46
74
83
37
22
-17
-1
54
Investing Cash Flow
-7
-4
-28
-15
-21
5
-129
31
26
Financing Cash Flow
-3
-20
-63
60
-27
-4
-1
-34
1
Change in Cash
33
24
-17
130
-13
15
-145
-6
90

Global Institutional Holdings in Pharming Group

Check out the Institutions with significant holdings in Pharming Group.

Funds
Holdings
Steward Funds Inc
0.02%
Fidelity Concord Street Trust
0.00%

Pharming Group News & Key Events

  • img

    Today's Timeline - 29 September

    Tue, 03:20 PM

    -

    Pharming announces CEO Fabrice Chouraqui steps down; Marsh and Lynard appointed as Interim Co-CEOs.

Insights on Pharming Group

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 72.44M → 90.21M (in $), with an average increase of 19.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -5.21M → 1.63M (in $), with an average increase of 418.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 93.4% return, outperforming this stock by 112.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 615.6% return, outperforming this stock by 650.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, PHAR stock has moved down by -32.1%

About Pharming Group

Pharming Group N.V. is a biopharmaceutical company dedicated to the creation and commercialization of protein replacement therapies and precision medicines. The firm concentrates its efforts on addressing rare diseases and critical unmet medical needs across the United States, Europe, and other international markets. Its primary commercialized product is Ruconest, a recombinant human C1 esterase inhibitor utilized for the acute treatment of hereditary angioedema. Pharming's development pipeline also includes rhC1INH, which is being investigated for conditions such as pre-eclampsia, acute kidney injury, and COVID-19. Additionally, the company is developing leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) inhibitor designed for patients with activated PI3K delta syndrome, as well as an alpha-glucosidase therapy targeting Pompe and Fabry diseases. The company has established significant collaborations, including a development and licensing agreement with Novartis. It also maintains a strategic partnership with Orchard Therapeutics plc for the research, development, manufacturing, and commercialization of OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy intended for hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands.
OrganisationPharming Group
HeadquartersDarwinweg 24, Leiden, ZH, 2333 CR, NL
IndustryBiotechnology
CEOFabrice Chouraqui

Key Management of Pharming Group

Name

Title

Ms. Mireille Sanders M.Sc.

Chief Operations Officer

Mr. Michael K. Levitan

VP of Investor Relations & Corporate Communications

Dr. Alexander Breidenbach M.B.A., Ph.D.

Chief Business Officer

Ms. Leverne Marsh BPHARM

Chief Commercial Officer

Mr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.

CEO & Executive Director

Mr. Kenneth Lynard EMBA, M.Sc.

Chief Financial Officer

Mr. Ruud Van Outersterp L.L.M.

Chief Legal & Compliance Officer and Company Secretary

Ms. Ines Bernal B.A.

Chief People Officer

Dr. Anurag Relan M.D., MPH

Chief Medical Officer

Dr. Magnus Hansson

Medical Director

FAQs

What is Pharming Group share price today?

Pharming Group share price today is $9.53 as on at the close of the market. Pharming Group share today touched a day high of $9.65 and a low of $9.44.

What is the 52 week high and 52 week low for Pharming Group share?

Pharming Group share touched a 52 week high of $21.34 on and a 52 week low of $9.44 on . Pharming Group stock price today i.e. is closed at $9.53,which is 55.34% down from its 52 week high and 0.94% up from its 52 week low.

What is Pharming Group's market capitalisation today?

Pharming Group market capitalisation is $0.00T as on .

How to invest in Pharming Group Stock (PHAR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pharming Group on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Pharming Group Stock (PHAR) from India?

Indian investors can start investing in Pharming Group (PHAR) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in Pharming Group stock (as per the Rupee-Dollar exchange rate as on ). Based on Pharming Group share’s latest price of $9.53 as on October 9, 2026 at 8:46 am IST, you will get 1.0493 shares of Pharming Group. Learn more about fractional shares .

What are the returns that Pharming Group has given to Indian investors in the last 5 years?

Pharming Group stock has given 1.17% share price returns and 28.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?